Your browser doesn't support javascript.
loading
Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).
Singh, Sheo B; Kaelin, David E; Wu, Jin; Miesel, Lynn; Tan, Christopher M; Gill, Charles; Black, Todd; Nargund, Ravi; Meinke, Peter T; Olsen, David B; Lagrutta, Armando; Wei, Changqing; Peng, Xuanjia; Wang, Xiu; Fukuda, Hideyuki; Kishii, Ryuta; Takei, Masaya; Takeuchi, Tomoko; Shibue, Taku; Ohata, Kohei; Takano, Hisashi; Ban, Shizuka; Nishimura, Akinori; Fukuda, Yasumichi.
Afiliação
  • Singh SB; Merck Research Laboratories, Kenilworth, NJ 07033, United States. Electronic address: sheo.singh.215@gmail.com.
  • Kaelin DE; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Wu J; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Miesel L; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Tan CM; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Gill C; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Black T; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Nargund R; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Meinke PT; Merck Research Laboratories, Rahway 07065, United States.
  • Olsen DB; Merck Research Laboratories, West Point, PA 19486, United States.
  • Lagrutta A; Merck Research Laboratories, West Point, PA 19486, United States.
  • Wei C; WuXi AppTec, Shanghai, People's Republic of China.
  • Peng X; WuXi AppTec, Shanghai, People's Republic of China.
  • Wang X; WuXi AppTec, Shanghai, People's Republic of China.
  • Fukuda H; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Kishii R; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takei M; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takeuchi T; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Shibue T; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Ohata K; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takano H; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Ban S; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Nishimura A; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Fukuda Y; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan. Electronic address: yasumichi.fukuda@gmail.com.
Bioorg Med Chem Lett ; 25(12): 2473-8, 2015 Jun 15.
Article em En | MEDLINE | ID: mdl-25978963

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Topoisomerase / Antibacterianos / Naftiridinas Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Topoisomerase / Antibacterianos / Naftiridinas Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido